Jupiter Neurosciences Inc (JUNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -8,645 | -2,440 | -4,784 | -4,958 |
| Depreciation Amortization | N/A | 43 | 17 | 558 |
| Accounts receivable | -3 | N/A | N/A | N/A |
| Other Working Capital | 109 | -2,566 | 2,348 | 1,549 |
| Other Operating Activity | 3,125 | 1,051 | 1,938 | 1,602 |
| Operating Cash Flow | $-5,414 | $-3,911 | $-481 | $-1,249 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 5,580 | -12 | 390 | 982 |
| Debt Repayment | -146 | -2,212 | N/A | N/A |
| Common Stock Issued | N/A | 150 | 55 | N/A |
| Other Financing Activity | 0 | 9,725 | 0 | 0 |
| Financing Cash Flow | $5,434 | $7,652 | $445 | $982 |
| Beginning Cash Position | 3,770 | 29 | 64 | 331 |
| End Cash Position | 3,789 | 3,770 | 29 | 64 |
| Net Cash Flow | $20 | $3,741 | $-36 | $-266 |
| Free Cash Flow | ||||
| Operating Cash Flow | -5,414 | -3,911 | -481 | -1,249 |
| Free Cash Flow | -5,414 | -3,911 | -481 | -1,249 |